Table 3

Health and economic outcomes among 20 cohorts vaccinated over 2011–2030 (2017 US$)

No vaccineWith vaccineAverted
Total cases573 685456 962116 724
Total non-severe pneumonia cases211 532200 95510 577
Total severe pneumonia cases347 831253 91793 914
Total pneumococcal meningitis cases1189591129
Total pneumococcal meningitis sequelae65433621
Total pneumococcal sepsis cases12 480199710 483
Total outpatient visits159 303150 4798554
Total hospitalisations297 927210 13887 789
Total pneumonia hospitalisations285 222208 21277 010
Total pneumococcal meningitis hospitalisations97549926
Total pneumococcal sepsis hospitalisations11 73018779854
Total deaths13 63391863336
Total pneumonia deaths12 35590193336
Total pneumococcal meningitis deaths33817321
Total pneumococcal sepsis deaths940150790
DALYs (discounted)290 587194 83795 750
Total government healthcare costs
(discounted)$13 696 698$9 739 493$3 957 205
Total outpatient visit costs$801 121$761 065$40 056
Total hospitalisation costs$12 895 577$8 978 428$3 917 149
Total societal healthcare costs
(discounted)$24 068 433$16 804 536$7 263 897
Total outpatient visit costs$2 234 169$15 727 762$661 407
Total hospitalisation costs$21 834 264$15 231 774$6 602 490
  • DALY, disability-adjusted-life-year.